Jessica founded Two Magnolias in 2019 with her business partner Marie Korde and serves as its Chief Executive Officer and Co-Founding Partner.
Jessica has led Two Magnolias from its early inception as an Angel investment vehicle in December 2019, through to its launch as an Early-Stage Venture Capital fund, achieving its first close in September of 2022, with the sole purpose of filling the clear opportunity gaps that are present in the UK Venture Capital ecosystem. This Fund was built on the founding principles of investing in entrepreneurs focused on Sustainability and Human Health solutions, based solely in the UK.
As CEO, Jessica is passionate about bringing a clear vision and lens to investment opportunities that exist within the Nations and Regions of the UK, that provide a clear and impactful outcome to local communities. Jessica’s involvement in strategically positioning the Fund to ensure that both female and ethnically diverse founders receive an equal voice has been identified as a critically important part of the drive for Equality within the UK’s Venture and Private Equity Industry.
Prior to building Two Magnolias, Jessica spent 30 years working in Investment Banking as a Global Markets expert, advising the world’s largest macro fund managers across fixed Income products. She spent her last 10 years at Bank of America, London as a Managing Director, and part of the EMEA leadership team holding significant revenue responsibility.
Jessica has been an investor in her own right with a personal portfolio that spans FinTech, EdTech, Sports Nutrition and Entertainment. She has strong international roots and was an early investor into funds focused on the advancement of Quantum Computing and Nature Based Advisory solutions.
Jessica is an Advisor and NED to companies that span the universe of climate change disruption to social impact. She currently sits as a NED of Balance Eco Ltd and Sing King Ltd.
Jessica holds a BSc in Management Science from Warwick University and is certified in Climate Change and Epidemiology at the Yale School of Public Health.